Publication | Closed Access

Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5′-deoxy-5-fluorocytidine, 5′-deoxy-5-fluorouridine, and 5-fluorouracil

Drug SafetyPharmacological StudyPharmacologySystemic ExposureClinical PharmacologyToxicologyPharmacotherapyRabeprazole IntakeMedicinePharmacological IssueClinical ToxicologyDrug Resistance